Function · 2023 · 11 citations · 49 references
Life SciencesCancer BiologyOncologyCell SignalingInflammationSignal TransductionCancer Cell SignalingCell Signaling NetworksImmune Cell SignalingInflammatory Cell SignalingInflammatory SignalingSignal Transduction In CancerCancer Signaling PathwaysCrispr-cas9 KnockoutCrispr-cas9 Knockout ModelsCyclooxygenase IsoformsCyclooxygenase-2 PathwayImmune Homeostasis RegulationLeukocyte ProliferationReceptor Serine/threonine Kinase Signaling
Abstract Cyclooxygenase-2 (COX-2) is a key regulator of inflammation. High constitutive COX-2 expression enhances survival and proliferation of cancer cells, and adversely impacts antitumor immunity. The expression of COX-2 is modulated by various signaling pathways. Recently, we identified the melastatin-like transient-receptor-potential-7 (TRPM7) channel-kinase as modulator of immune homeostasis. TRPM7 protein is essential for leukocyte proliferation and differentiation, and upregulated in several cancers. It comprises of a cation channel and an atypical α-kinase, linked to inflammatory cell signals and associated with hallmarks of tumor progression. A role in leukemia has not been established, and signaling pathways are yet to be deciphered. We show that inhibiting TRPM7 channel-kinase in chronic myeloid leukemia (CML) cells results in reduced constitutive COX-2 expression. By utilizing a CML-derived cell line, HAP1, harboring CRISPR/Cas9-mediated TRPM7 knockout, or a point mutation inactivating TRPM7 kinase, we could link this to reduced activation of AKT serine/threonine kinase and mothers against decapentaplegic homolog 2 (SMAD2). We identified AKT as a direct in vitro substrate of TRPM7 kinase. Pharmacologic blockade of TRPM7 in wildtype HAP1 cells confirmed the effect on COX-2 via altered AKT signaling. Addition of an AKT activator on TRPM7 kinase-dead cells reconstituted the wildtype phenotype. Inhibition of TRPM7 resulted in reduced phosphorylation of AKT and diminished COX-2 expression in peripheral blood mononuclear cells derived from CML patients, and reduced proliferation in patient-derived CD34+ cells. These results highlight a role of TRPM7 kinase in AKT-driven COX-2 expression and suggest a beneficial potential of TRPM7 blockade in COX-2-related inflammation and malignancy.
49
LTRPC7 is a Mg·ATP-regulated divalent cation channel required for cell viability
Monica J. S. Nadler, Meredith C. Hermosura, Kazunori Inabe et al. · Nature · 2001 · 931 citations
Regulation of Vertebrate Cellular Mg2+ Homeostasis by TRPM7
Carsten Schmitz, Anne‐Laure Perraud, Catherine O. Johnson et al. · Cell · 2003 · 725 citations · Full text
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Samuel Huber, Nicola Gagliani, Lauren A. Zenewicz et al. · Nature · 2012 · 705 citations